34 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
and provide R&D and upfront funding, and internal programs for which we have more control and the potential for partnerships or asset sales that provide … of partnerships to address additional classes of molecules, thereby presenting additional milestone and royalty opportunities. Grow our platform through R&D
8-K
EX-99.1
ABSI
Absci Corp
21 Mar 24
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
7:31am
as the Executive Vice President of BioPharmaceuticals R&D at AstraZeneca, and joins Absci as the company scales its AI-enabled portfolio of partnered and wholly
424B5
ABSI
Absci Corp
28 Feb 24
Prospectus supplement for primary offering
8:34am
that broaden our reach into various indications and provide R&D and upfront funding, and internal programs for which we have more control and the potential
8-K
y85ahm9 91ejy2gl
27 Feb 24
Results of Operations and Financial Condition
4:45pm
424B5
ceel4gpfr 9ptwlssin
27 Feb 24
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
i8qxi2l
8 Jan 24
Absci Corporation 2024 All Rights Reserved 42ND JP Morgan Healthcare Conference
7:08am
8-K
EX-99.1
xmgpyxl
20 Dec 23
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
8:30am
8-K
xvzty4pmi v9cis
20 Dec 23
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
8:30am
8-K
w231 fqsxc
7 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-99.1
ms1x 564kw
4 Dec 23
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
7:31am
8-K
EX-99.2
mqhka9
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm
8-K
EX-99.1
v1kjmyq
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm
8-K
EX-99.1
pywo m8okkat6
14 Aug 23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
8:13am
ARS
e511z9bx
28 Apr 23
Annual report to shareholders
12:00am
PRE 14A
gmlod98x06pp269uzw8
11 Apr 23
Preliminary proxy
5:49pm
8-K
EX-99.1
cxhwwht2nymo5g76 tiv
9 Nov 22
Absci Reports Third Quarter 2022 Financial Results
9:18am